Search results
Results from the WOW.Com Content Network
Botulinum toxin produced by Clostridium botulinum (an anaerobic, gram-positive bacterium) is the cause of botulism. [25] Humans most commonly ingest the toxin from eating improperly canned foods in which C. botulinum has grown. However, the toxin can also be introduced through an infected wound.
Pfizer: Off-label promotion of Bextra, Geodon, Zyvox and Lyrica, September 2009. In what was the largest pharmaceutical settlement in U.S. history at the time, Pfizer reached a $2.3 billion settlement with the Department of Justice to resolve criminal charges and civil claims under the False Claims Act.
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial ...
Sources say the pharmaceutical company that manufactures Botox, Allergan, charges providers around $6-7 per unit, making the average patient cost more like $10-15 per unit (with metropolitan areas ...
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. [1] [2] [3] The company is the maker of Botox.
The maker of Botox Allergan will be bought by Abbvie in a cash and stock deal valued at about $63 billion. Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Connor Browne, a portfolio ...
The cost of the surgery can be significant. According to ASPS, the average cost of a surgeon’s fee for cosmetic breast reduction is $6,771. Additional fees may include anesthesia and hospital or ...
In 2003, data from the Medical Expenditure Panel Survey showed that only 9.5% of Americans with Medicare coverage had no prescription drug expenses, while 61.6% had prescription drug expenses up to $2,083, and 28.9% of those on Medicare had expenses higher than $2,084.